Figure 3From: Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy Electropherogram derived from patient’s tumor sample showing a point mutation at codon 600 (GTG to GAG) resulting in a Valine (V) to Glutamic acid (E) substitution. Back to article page